Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Non-Current Assets (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Non-Current Assets came in at $23.7 billion in Q2 2026, up 6.14% year-over-year from $22.3 billion in Q2 2025, and up 0.85% quarter-over-quarter from $23.5 billion in Q1 2026.

Analysis

Iqvia Holdings (IQV) Non-Current Assets (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Non-Current Assets across 15 years of filings, most recently posting $23.7 billion for Q2 2026.

  • In Q2 2026, Non-Current Assets rose 6.14% year-over-year to $23.7 billion; the TTM figure through Jun 2026 stood at $93.6 billion (up 8.38% YoY), while the FY2025 annual figure was $23.7 billion, up 12.46% from the prior year.
  • Non-Current Assets came in at $23.7 billion for Q2 2026 at Iqvia Holdings, up from $23.5 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $23.7 billion in Q4 2025 to a low of $19.5 billion in Q3 2022.
  • Average Non-Current Assets over 5 years is $21.3 billion, with a median of $21.0 billion recorded in 2024.
  • Year-over-year, Non-Current Assets retreated 0.14% in 2022 and grew 12.46% in 2025.
  • Over 5 years, Non-Current Assets stood at $20.4 billion in 2022, then grew by 3.58% to $21.1 billion in 2023, then dropped by 0.07% to $21.1 billion in 2024, then rose by 12.46% to $23.7 billion in 2025, then slipped by 0.17% to $23.7 billion in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $23.7 billion in Q2 2026, $23.5 billion in Q1 2026, and $23.7 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 23.66 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 1.01 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 12.65 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 6.00 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 1.79 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 982.30 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 657.51 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 14.00 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 3.66 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 621,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.66 Bn
Mar 31, 2026 23.46 Bn
Dec 31, 2025 23.70 Bn
Sep 30, 2025 22.75 Bn
Jun 30, 2025 22.29 Bn
Mar 31, 2025 21.41 Bn
Dec 31, 2024 21.07 Bn
Sep 30, 2024 21.55 Bn
Jun 30, 2024 20.78 Bn
Mar 31, 2024 20.92 Bn
Dec 31, 2023 21.09 Bn
Sep 30, 2023 20.77 Bn
Jun 30, 2023 20.71 Bn
Mar 31, 2023 20.41 Bn
Dec 31, 2022 20.36 Bn
Sep 30, 2022 19.47 Bn
Jun 30, 2022 19.50 Bn
Mar 31, 2022 20.20 Bn
Dec 31, 2021 19.93 Bn
Sep 30, 2021 19.50 Bn